Advertisement

Topics

Global Neurodegenerative Diseases Market 20152019 Prices from USD $3500

13:07 EST 1 Dec 2016 | BioPortfolio Reports

About neurodegenerative diseases
According to the EU JPND, neurodegenerative diseases refer to conditions that involve the neurons in the brain. These conditions can affect balance, movement, speech, and respiratory and cardiac functions. They can be inherited or be of unknown etiology. Neurodegenerative diseases are incurable and are severely debilitating. They result in progressive degeneration of nerve cells, causing them to die eventually. These diseases cause ataxia and dementia in people, which can have a serious impact on the mental health of patients. Some examples of neurodegenerative diseases are Alzheimer's disease, Parkinson's disease, Huntington's disease, multiple sclerosis, amyotrophic lateral sclerosis, and epilepsy. Huntington's disease and amyotrophic lateral sclerosis are rare diseases, unlike Alzheimer's disease and Parkinson's disease which have a high degree of prevalence.
Technavio's analysts forecast the global neurodegenerative diseases market to grow at a CAGR of 4.77 percent over the period 20142019.
Covered in this report
This report covers the present scenario and the growth prospects of the global neurodegenerative diseases market for the period 20152019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of neurodegenerative diseases. The market includes data from the sales of various drugs used in the treatment of:
Alzheimer's Disease
Parkinson's Disease
Multiple Sclerosis
Epilepsy
Huntington's Disease
Amyotrophic Lateral Sclerosis
The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the global neurodegenerative diseases market. The vendor landscape section includes a market share analysis of the major vendors along with the performances of their product portfolios. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by vendors and the market at large, as well as the key trends that are emerging in the market. In addition, latestage pipeline molecules developed for the treatment of neurodegenerative diseases are discussed.
Technavio's report, Global Neurodegenerative Diseases Market 20152019, has been prepared based on an indepth market analysis with inputs from industry experts. The report covers the Americas, the EMEA, and the APAC; it also covers the global neurodegenerative diseases market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key regions
Americas
APAC
EMEA
Key vendors
Biogen Idec
Merck Serono
Novartis
Pfizer
Teva Pharmaceutical Industries
UCB
Other prominent vendors

AB Science
Abbvie
Acorda Therapeutics
Actavis
Active Biotech
Adamas Pharmaceuticals
Akorn
Archer Pharmaceuticals
Astellas
Auspex Pharmaceuticals
Bayer
Boehringer Ingelheim
Covis
Desitin Arzneimittel
Eisai
Eli Lilly
Endo International
F. HoffmannLa Roche
FORUM Pharmaceuticals
GlaxoSmithKline
Glenmark
H. Lundbeck
Ipsen
Janssen Pharmaceuticals
Kyowa Hakko Kirin
Mitsubishi Tanabe
MorphoSys
Newron Pharmaceuticals
Omeros
Opexa
Orion
Otsuka Pharmaceutical
Oxford BioMedica
Palobiofarma
Prana Biotechnology
Raptor Pharmaceutical
Sanofi
Siena Biotech
SOM Biotech
STADA
Takeda Pharmaceutical
TauRx Pharmaceuticals
US WorldMeds
Valeant
Zinfandel Pharmaceuticals
Market driver
High unmet medical needs
For a full, detailed list, view our report
Market challenge
Generic erosion
For a full, detailed list, view our report
Market trend
Reformulation of marketed drugs
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Original Article: Global Neurodegenerative Diseases Market 20152019 Prices from USD $3500

NEXT ARTICLE

More From BioPortfolio on "Global Neurodegenerative Diseases Market 20152019 Prices from USD $3500"

Quick Search
Advertisement
 

Relevant Topics

Respiratory
Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...

Mental Health
Adhd Anorexia Depression Dyslexia Mental Health Psychiatry Schizophrenia Stress Mental health, although not being as obvious as physical health, is very important, causing great unhappiness to those affected, causing add...